Viswanathan co-founded the company in 2016 and previously served as President
Appointment ushers in new growth phase for Truepill following $142M Series D, $1.6B valuation, and launch of innovative suite of COVID-19 solutions
Sid Viswanathan
Viswanathan co-founded the company in 2016 and previously served as President
Appointment ushers in new growth phase for Truepill following $142M Series D, $1.6B valuation, and launch of innovative suite of COVID-19 solutions